⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 1 July, 2019    By - Dr Clemens
General Anesthesia Versus Conscious Sedation for Intracranial Mechanical Thrombectomy

Authors: Yu Zhang et al Journal of the American Heart Association  18 Jun 2019  Background Endovascular therapy is the standard of care for severe acute ischemic stroke caused by large‐vessel occlusion in the anterior circulation, but there is uncertainty regarding the optimal anesthetic approach during this therapy. Meta‐analyses of observational studies suggest that general anesthesia […]

Read More
Uncategorized Published - 1 July, 2019    By - Dr Clemens
The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG)

Authors: Yanting Zhang et al  BMC Anesthesiology 2019 19:104 Background The safety and efficiency of intravenous administration of tranexamic acid (TXA) in coronary artery bypass grafting (CABG) remains unconfirmed. Therefore, we conducted a meta-analysis on this topic. Methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PUBMED and EMBASE for randomized controlled trials […]

Read More
Uncategorized Published - 1 July, 2019    By - Dr Clemens
Remifentanil patient-controlled intravenous analgesia during labour: a retrospective observational study of 10 years’ experience

Authors: H. Murray et al International Journal of Obstetric Anesthesia May 2019 Highlights •More than 80% of 8100 women using remifentanil were satisfied with labour analgesia. •Monitoring relies heavily on the constant presence of a midwife. •Over 50% of women using remifentanil required supplemental oxygen. •Apgar scores were not less favourable than for epidural or […]

Read More
Uncategorized Published - 1 July, 2019    By - Dr Clemens
FDA approves Lilly’s migraine drug as first ever cluster headache treatment

This is good for our readers who treat chronic pain patients. Author: Michael Erman Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks, the Food and Drug Administration said. Emgality belongs to a new class of drugs called […]

Read More
Uncategorized Published - 1 July, 2019    By - Dr Clemens
The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS)

Authors: Corl, Keith A. MD, ScM et al Critical Care Medicine: July 2019 – Volume 47 – Issue 7 – p 951-959 Objectives: It is unclear if a low- or high-volume IV fluid resuscitation strategy is better for patients with severe sepsis and septic shock. Design: Prospective randomized controlled trial. Setting: Two adult acute care hospitals within a single academic system. […]

Read More